Cabozantinib Oral Tablet
IRB-300012653
Phase 1 small_molecule active
Quick answer
Cabozantinib Oral Tablet for Neurofibromatosis 1 is a Phase 1 program (small_molecule) at United Therapeutics Europe Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- United Therapeutics Europe Ltd
- Indication
- Neurofibromatosis 1
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active